Presidential Arm Twisting: Drug Pricing Order Would Advance International Benchmarks Unless Industry Offers Alternative

Industry has 30 days to come up with a better idea that would “end foreign free riding” and close the gap between drug prices in the US and abroad, President Trump says. Administration also wants to revive rebate reform.

Trump_Donald_160716_1200x675
Order Aims To Pressure Industry Into Response

President Trump unveiled four executive orders on drug pricing 24 July, including a directive to advance international reference pricing for lowering Medicare Part B drug costs unless industry offers an alternative solution in the next 30 days to “end foreign free-riding.”

The orders were announced to bolster the Administration’s record on lowering drug pricing as the presidential election approaches. But it...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Pricing Debate

More from Market Access